HUMA
Humacyte·NASDAQ
--
--(--)
--
--(--)
1.84 / 10
Underperform
Technical rating is weak at 1.84/10. Dominant bearish signals—MACD Death Cross, Long Lower Shadow, and Long Upper Shadow—imply downward momentum and limited near-term upside. Traders should be mindful of continued downside risk until a clear reversal pattern emerges.
Analysis Checks(0/3)
Long Lower Shadow
Score2.65/10
Win Rate46.77%
Hist. Signals62
Avg Return0.27%
Score2.65/10
Win Rate46.77%
Hist. Signals62
Avg Return0.27%
MACD Death Cross
Score1.87/10
Win Rate44.44%
Hist. Signals9
Avg Return-2.17%
Score1.87/10
Win Rate44.44%
Hist. Signals9
Avg Return-2.17%
Long Upper Shadow
Score1/10
Win Rate32.31%
Hist. Signals65
Avg Return-1.27%
Score1/10
Win Rate32.31%
Hist. Signals65
Avg Return-1.27%
Long Lower Shadow
Score2.65/10
Win Rate46.77%
Hist. Signals62
Avg Return0.27%
Score2.65/10
Win Rate46.77%
Hist. Signals62
Avg Return0.27%
Long Upper Shadow
Score1/10
Win Rate32.31%
Hist. Signals65
Avg Return-1.27%
Score1/10
Win Rate32.31%
Hist. Signals65
Avg Return-1.27%
MACD Death Cross
Score1.87/10
Win Rate44.44%
Hist. Signals9
Avg Return-2.17%
Score1.87/10
Win Rate44.44%
Hist. Signals9
Avg Return-2.17%
Technical Analysis of HUMA?
- HUMA presents a Underperform setup with a Technical Score of 1.84/10. Key technical indicators highlight an RSI of 40.43 and a MACD of -0.02, with the trend anchored by the 50-Day SMA at 1.12. Traders should monitor key support at 0.86 and resistance at 0.94.
